Cargando…
The global origins of resistance-associated variants in the non-structural proteins 5A and 5B of the hepatitis C virus
New, costly, fast acting, therapies targeting the non-structural proteins 5A and 5B (NS5A and NS5B) regions of the hepatitis C virus (HCV) genome are curative in the majority of cases. Variants with certain mutations in the NS5A and NS5B regions of HCV have been shown to reduce susceptibility to dir...
Autores principales: | Jones, Bradley R, Howe, Anita Y M, Harrigan, P Richard, Joy, Jeffrey B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769712/ https://www.ncbi.nlm.nih.gov/pubmed/29362671 http://dx.doi.org/10.1093/ve/vex041 |
Ejemplares similares
-
Intra-host evolutionary dynamics of the hepatitis C virus among people who inject drugs
por: Montoya, Vincent, et al.
Publicado: (2021) -
SHARED: An International Collaboration to Unravel Hepatitis C Resistance
por: Howe, Anita Y.M., et al.
Publicado: (2021) -
Validation of a Genotype-Independent Hepatitis C Virus Near-Whole Genome Sequencing Assay
por: Lapointe, Hope R., et al.
Publicado: (2021) -
Impact of an Open Access Nationwide Treatment Model on Hepatitis C Virus Antiviral Drug Resistance
por: Douglas, Mark W., et al.
Publicado: (2020) -
Resistance-Associated NS5A Variants of Hepatitis C Virus Are Susceptible to Interferon-Based Therapy
por: Itakura, Jun, et al.
Publicado: (2015)